Maria Kontaridis | Medicine and Health Sciences | Best Researcher Award

Dr. Maria Kontaridis | Medicine and Health Sciences | Best Researcher Award

Medicine and Health Sciences | Executive Director at Masonic Medical Research Institute, United States

Dr. Maria Irene Kontaridis is a distinguished biomedical scientist and academic leader with an extensive background in cardiovascular research, molecular pharmacology, and translational medicine. She holds dual undergraduate degrees from the University of Florida and advanced degrees, including a Ph.D. in Biological and Biomedical Sciences from Yale University, where she also completed a Mini MBA. Her postdoctoral training at Yale and Harvard laid the foundation for a prolific career marked by influential faculty appointments at Harvard Medical School and Beth Israel Deaconess Medical Center. Currently serving as Executive Director and Gordon K. Moe Professor at the Masonic Medical Research Institute, she oversees strategic research initiatives, institutional growth, and scientific innovation. Dr. Kontaridis has led major national and international symposia, contributed to scientific and community development efforts, and is an advocate for women in science and academic leadership. Her interdisciplinary expertise, combined with her administrative acumen and philanthropic outreach, has positioned her as a transformative figure in biomedical research and academic medicine.

Professional ProfileΒ 

πŸŽ“ Education of Dr. Maria Kontaridis

Dr. Maria Kontaridis has an exceptional academic foundation marked by interdisciplinary excellence. She earned two undergraduate degrees in 1995 from the University of Floridaβ€”a B.S. in Chemistry (Cum Laude) with a Minor in Business Administration, and a B.A. in Classical Studies (Summa Cum Laude). She pursued advanced scientific training at Yale University, completing a Master of Science (M.S.) in Pharmacology and Molecular Medicine in 1998, followed by an M.Phil. in 1999, and a Ph.D. in Biological and Biomedical Sciences in 2002 under the mentorship of Dr. Anton Bennett. Further enhancing her academic versatility, she obtained a Mini Master of Business Administration Certificate from Yale in 2000. In recognition of her scientific achievements and leadership, she was awarded an honorary Doctor of Science (D.Sc. h.c.) in 2025 by SUNY Polytechnic Institute, solidifying her stature as a leader in biomedical education and research.

πŸ’Ό Professional Experience of Dr. Maria Kontaridis

Dr. Maria Kontaridis has built a distinguished career in biomedical research, academic leadership, and institutional development. She began her professional journey with postdoctoral fellowships at Yale University and Harvard Medical School, focusing on pharmacology and hematology/oncology under the mentorship of esteemed scientists. Her academic appointments include progressive faculty roles at Harvard Medical School, where she served as Instructor, Assistant Professor, and later Associate Professor of Medicine, contributing to research, mentorship, and program development across multiple departments. She also held leadership roles at Beth Israel Deaconess Medical Center, including Director of Basic Cardiovascular Research and Faculty in Cardiovascular Medicine. Currently, she is the Gordon K. Moe Professor and Chair of Biomedical Research and Translational Medicine and the Executive Director at the Masonic Medical Research Institute (MMRI) in Utica, New York. At MMRI, she leads a team of over 60 researchers and staff, spearheads strategic initiatives, manages multimillion-dollar fundraising efforts, and drives national and international collaborationsβ€”making her a dynamic force in advancing cardiovascular and translational medicine.

πŸ”¬ Research Interests of Dr. Maria Kontaridis

Dr. Maria Kontaridis’s research is centered on unraveling the molecular mechanisms underlying cardiovascular diseases, congenital heart defects, and RASopathiesβ€”a group of genetic syndromes caused by mutations in the RAS-MAPK pathway. Her work explores signal transduction pathways, particularly focusing on protein phosphatases, kinases, and their role in cardiac development, function, and remodeling. She has a strong interest in translational medicine, aiming to bridge the gap between basic science and clinical application by identifying novel therapeutic targets for heart failure, arrhythmias, and vascular abnormalities. Through her leadership at the Masonic Medical Research Institute, she has expanded her research scope to include regenerative medicine, stem cell biology, and precision medicine approaches for complex cardiovascular disorders. Her interdisciplinary focus integrates molecular biology, genetics, and pharmacology to develop innovative strategies for diagnosis and treatment, with a goal of improving patient outcomes in both pediatric and adult populations.

πŸ… Awards and Honors of Dr. Maria Kontaridis

Dr. Maria Kontaridis has received numerous prestigious awards and honors that recognize her scientific excellence, leadership, and contributions to biomedical research. One of her most distinguished accolades is the Doctor of Science, honoris causa (D.Sc. h.c.), awarded by SUNY Polytechnic Institute in 2025, reflecting her impact on science and public service. Throughout her career, she has been appointed to prominent academic and leadership positions, such as the Gordon K. Moe Professorship and Executive Director at the Masonic Medical Research Institute, affirming her influence in the field of cardiovascular medicine. She has also been invited to chair and organize major international symposia and scientific meetings, including the Sarnoff Cardiovascular Research Foundation Annual Meeting and the International RASopathies Symposium. Additionally, her recognition extends beyond academia into civic and economic development, where she serves on advisory and leadership boards, underlining her role as a visionary leader committed to advancing both science and society.

🏁 Conclusion

Dr. Maria Irene Kontaridis is highly suitable and deserving of the Best Researcher Award. Her career exemplifies excellence in academic leadership, global research collaboration, translational science, and mentorship. Her deep commitment to advancing cardiovascular medicine and biomedical innovation, combined with community involvement and advocacy for women in science, sets a benchmark for what this award represents.

πŸ“š Publications Top Noted

  1. Title: SHP2 happens, just sail with it: the role of the protein tyrosine phosphatase SHP2 in autoimmune and autoinflammatory diseases
    Type: Review (Open Access)
    Authors: Not listed in preview
    Year: Not specified
    Citations: 0

  2. Title: Modulating the Secretome of Fat to Treat Heart Failure
    Type: Review
    Authors: Not listed in preview
    Year: Not specified
    Citations: 1

  3. Title: Interorgan Crosstalk in Heart Failure and Cardiometabolic Diseases: A Compendium
    Type: Review
    Authors: Not listed in preview
    Year: Not specified
    Citations: 0

  4. Title: RASopathies in Cardiac Disease
    Type: Review (Open Access)
    Authors: Not listed in preview
    Year: Not specified
    Citations: 0

  5. Title: SHP2 as a primordial epigenetic enzyme expunges histone H3 pTyr-54 to amend androgen receptor homeostasis
    Type: Research Article
    Journal: Nature Communications
    Authors: Not fully listed; Dr. Maria Kontaridis is one of them
    Year: 2024
    Citations: 6

 

 

Jih Ru Hwu | Medicine and Health Sciences | Lifetime achievement Award

Prof. Jih Ru Hwu | Medicine and Health Sciences | Lifetime achievement Award

Distinguished Chair Professor at National Tsing Hua University, Taiwan

Professor Reuben Jih-Ru Hwu is a Distinguished Chair Professor Emeritus with Lifetime Honor at National Tsing Hua University, Taiwan, and a globally recognized chemist whose career spans over four decades of pioneering research and academic excellence. Earning his Ph.D. from Stanford University in 1982, he served as a faculty member at Johns Hopkins University before returning to Asia, where he built an outstanding interdisciplinary research portfolio in drug design, DNA-cleaving agents, nano-biomaterials, organosilicon chemistry, natural product synthesis, and green chemistry. With over 253 publications and 52 patents, his contributions reflect both scientific rigor and practical innovation. Professor Hwu has been honored with numerous prestigious awards, including the TWAS Award, the Chinese American Chemical Society’s Outstanding Achievement Award, and the Taiwan National Chair Professorship. He is a Fellow of esteemed organizations such as TWAS, IUPAC, the Royal Society of Chemistry, and the European Academy of Sciences and Arts. His leadership roles, including presidencies of major chemical societies such as FACS and the Asian Federation for Medicinal Chemistry, further underscore his influential presence in the global scientific community.

Professional ProfileΒ 

πŸŽ“ Education of Professor Reuben Jih-Ru Hwu

Professor Reuben Jih-Ru Hwu began his academic journey with a strong foundation in chemistry, culminating in a Ph.D. in Chemistry from the prestigious Stanford University in 1982. His doctoral training at Stanford equipped him with cutting-edge expertise in chemical research, setting the stage for his impactful scientific career. Prior to that, he demonstrated exceptional academic promise, which was later recognized through multiple international awards and fellowships. His educational background reflects both academic excellence and a commitment to innovation, shaping him into a global leader in multidisciplinary chemical sciences.

πŸ’Ό Professional Experience of Professor Reuben Jih-Ru Hwu

Professor Reuben Jih-Ru Hwu has had a distinguished professional career marked by academic leadership, research excellence, and international collaboration. After earning his Ph.D. from Stanford University in 1982, he began his academic tenure as a faculty member at Johns Hopkins University, where he served from 1982 to 1991. He later returned to Taiwan and became a Distinguished Chair Professor at National Tsing Hua University, where he was eventually honored as Professor Emeritus with Lifetime Honor. Throughout his career, Professor Hwu has led groundbreaking research across diverse areas such as medicinal chemistry, nano-biomaterials, green chemistry, and synthetic methodology. He has also held key leadership roles in international scientific organizations, including serving as President of the Chinese American Chemical Society, the Asian Federation for Medicinal Chemistry, and the Federation of Asian Chemical Societies, demonstrating his global impact and commitment to advancing chemical sciences worldwide.

πŸ”¬ Research Interests of Professor Reuben Jih-Ru Hwu

Professor Reuben Jih-Ru Hwu’s research interests span a broad and impactful spectrum of chemical sciences, reflecting his passion for innovation and interdisciplinary exploration. His work encompasses drug design and synthesis, the development of DNA-cleaving agents, and the creation of advanced nano-biomaterials for biomedical applications. He has made significant contributions to natural product synthesis, organosilicon chemistry, and the discovery of novel chemical reactions and reagents. In recent years, Professor Hwu has also focused on sustainability and green chemistry, aiming to develop eco-friendly chemical processes. His diverse and forward-looking research not only advances scientific knowledge but also addresses critical global challenges in health, environment, and technology.

πŸ… Awards and Honors of Professor Reuben Jih-Ru Hwu

Professor Reuben Jih-Ru Hwu has received numerous prestigious awards and honors that reflect his outstanding contributions to the chemical sciences. Notable recognitions include the 2023 Outstanding Achievement Award from the Chinese American Chemical Society, the Gulf Chemistry Association Trophy (2022), and the CAS Registry Innovator Award (2022). He has also been honored with the Taiwan National Chair Professorship, the TWAS Award (1997), and was named one of the JCI Ten Outstanding Young Persons of the World (1994). Earlier in his career, he received the FACS Distinguished Young Chemist Award (1992–93), the Alfred P. Sloan Research Fellowship (1986–1990), and the Stuart Pharmaceuticals Achievement Award (1986). His accolades span decades and continents, highlighting his influence in both academic and applied chemistry. These awards are a testament to his innovation, leadership, and lifelong dedication to advancing science.

βœ…Conclusion

Professor Reuben Jih-Ru Hwu is a highly qualified and exceptional candidate for the Best Researcher Award. His prolific academic output, international recognitions, scientific leadership, and broad research contributions place him among the top-tier scientists in the field of chemistry and interdisciplinary sciences. With slight enhancement in showcasing his recent impactful contributions and societal influence, his nomination would not only be justified but compelling on a global scale.

πŸ“š Publications

1. Calcium Impregnated Silica Gel in the Domino Reaction Involving Irreversible Aldol Addition, Dehydration, and Michael Addition

  • Title: Calcium Impregnated Silica Gel in the Domino Reaction Involving Irreversible Aldol Addition, Dehydration, and Michael AdditionAuthors: Jihβ€―Ruβ€―Hwu, Khagendra Prasad Bohara, Mohit Kapoor, etβ€―al. (with collaborators from National Tsing Hua University and affiliated institutes)
  • Journal: Journal of Organic Chemistry
  • Year: 2025 (published ~2 months ago from June 2025)
  • Citations: 0

2. 6‑Chlorocoumarin Conjugates with Nucleobases and Nucleosides as Potent Anti‑Hepatitis C Virus Agents

  • Title: 6‑Chlorocoumarin Conjugates with Nucleobases and Nucleosides as Potent Anti‑HepatitisΒ C Virus Agents
  • Authors: Shu‑Yuβ€―Lin, Wen‑Chiehβ€―Huang, Shwu‑Chenβ€―Tsay, Johanβ€―Neyts, Pieterβ€―Leyssen, Chun‑Chengβ€―Lin, Kuoβ€―Chuβ€―Hwang, Jia‑Cherngβ€―Horng, and Jihβ€―Ruβ€―Hwu
  • Journal: Molecules (Open access)
  • Year: 2025 (Volume 30, Issue 8, Article 1776)
  • Citations: 0

 

 

Alexandre Marcolino | Medicine and Health Sciences | Best Researcher Award

Prof. Dr. Alexandre Marcolino | Medicine and Health Sciences | Best Researcher Award

The Patient Specific Functional Scale at Federal University of Santa Catarina, Brazil

Dr. Alexandre Marcio Marcolino is a distinguished Brazilian physiotherapist and researcher, currently serving as an Adjunct Professor at the Universidade Federal de Santa Catarina (UFSC). With a Ph.D. in Physiotherapy and Functional Performance and a Master’s in Health Sciences applied to the Locomotor System from the prestigious Faculdade de Medicina de RibeirΓ£o Preto – USP, Dr. Marcolino has built a career centered on advanced musculoskeletal rehabilitation, low-intensity laser therapy, and electromyography. His academic journey includes specializations in hand therapy and orthopedic physiotherapy, complemented by a postdoctoral fellowship at UFSCAR. Actively involved in teaching, research, academic advisory, and program coordination, he also demonstrates a strong commitment to continuing education through numerous certifications and professional courses. His research, technical production, and contributions to clinical physiotherapy and academic leadership make him a notable figure in rehabilitation sciences in Brazil.

Professional ProfileΒ 

πŸŽ“ Education of Alexandre Marcio MarcolinoΒ 

Dr. Alexandre Marcio Marcolino holds a robust academic background in the field of physiotherapy and rehabilitation. He earned his undergraduate degree in Physiotherapy from Faculdade de Filosofia, CiΓͺncias e Letras de Catanduva in 2004, where he conducted early research on laser therapy in ischemic skin flaps. He went on to complete a Master’s degree in Health Sciences Applied to the Locomotor System (2009) and a Doctorate in Physiotherapy and Functional Performance (2013) at the Faculdade de Medicina de RibeirΓ£o Preto – USP, focusing on laser therapy in nerve regeneration and electromyographic analysis in wrist orthoses, respectively. Additionally, he has completed two specializationsβ€”one in Hand Therapy at the Instituto de Ortopedia e Traumatologia (USP), and another in Orthopedic Physiotherapy at the Hospital das ClΓ­nicas de RibeirΓ£o Preto. Further advancing his academic career, Dr. Marcolino completed a postdoctoral fellowship at the Universidade Federal de SΓ£o Carlos (2020–2021). His commitment to lifelong learning is further demonstrated by over 30 professional development courses in areas such as electromyography, manual therapy, pedagogy, systematic reviews, and digital tools for education.

πŸ’Ό Professional Experience of Alexandre Marcio MarcolinoΒ 

Dr. Alexandre Marcio Marcolino has amassed extensive professional experience in academia, clinical practice, and research within the field of physiotherapy. Since 2015, he has served as an Adjunct Professor at the Universidade Federal de Santa Catarina (UFSC), where he is actively involved in teaching undergraduate and postgraduate courses, supervising research in the Postgraduate Program in Rehabilitation Sciences, and contributing to academic administration, including roles such as program coordinator and departmental delegate. His clinical and academic expertise spans orthopedics and traumatology, with a focus on electromyography, rehabilitation techniques, and musculoskeletal disorders. Prior to his tenure at UFSC, he worked as a professor at the Universidade Estadual de GoiΓ‘s (UEG) and gained hands-on clinical experience as a physiotherapist at the Casa de Repouso BrandΓ£o and through his residency at the Hospital das ClΓ­nicas da Faculdade de Medicina de RibeirΓ£o Preto – USP. Dr. Marcolino’s diverse professional background integrates clinical proficiency, academic leadership, and a strong research orientation, making him a key contributor to the advancement of physiotherapy in Brazil.

πŸ”¬ Research Interests of Alexandre Marcio MarcolinoΒ 

Dr. Alexandre Marcio Marcolino’s research interests are centered on advancing clinical practices in physiotherapy through evidence-based approaches in musculoskeletal rehabilitation and neurofunctional recovery. He has a strong focus on electromyography, biomechanical analysis, and the application of low-intensity laser therapy for tissue repair and nerve regenerationβ€”particularly in experimental models of peripheral nerve injury. His academic investigations also explore the therapeutic effects of orthotic devices, muscle activation patterns, and functional performance, especially in conditions like lateral epicondylitis. Additionally, Dr. Marcolino is deeply engaged in interdisciplinary studies that intersect biomechanics, manual therapy, and innovative physiotherapeutic techniques aimed at improving clinical outcomes. His commitment to scientific rigor and translational research reflects a broader vision to enhance rehabilitation protocols and contribute to the development of high-impact, patient-centered care models.

πŸ… Awards and Honors of Alexandre Marcio MarcolinoΒ 

Dr. Alexandre Marcio Marcolino has been recognized for his academic excellence and research contributions through prestigious awards and honors throughout his career. Notably, he received a postdoctoral research fellowship from the Conselho Nacional de Desenvolvimento CientΓ­fico e TecnolΓ³gico (CNPq)β€”a significant acknowledgment of his scholarly merit and potential for advancing rehabilitation sciences in Brazil. Earlier in his career, he was also granted a scholarship from FUNDAP (FundaΓ§Γ£o do Desenvolvimento Administrativo) during his specialization in orthopedic physiotherapy at the renowned Hospital das ClΓ­nicas da Faculdade de Medicina de RibeirΓ£o Preto – USP. These honors reflect his dedication to scientific advancement, clinical excellence, and ongoing contributions to the field of physiotherapy.

βœ… Conclusion

Dr. Alexandre Marcio Marcolino is a highly suitable candidate for the Best Researcher Award in the health and rehabilitation sciences. His profound academic qualifications, consistent research contributions, and dedication to education, combined with a diversified skill set in therapy techniques and bioinstrumentation, place him among top-tier professionals in Brazilian physiotherapy research.

πŸ“ Selected Publications by Dr. Shahrokh Javaheri

  1. Title: Photobiomodulation (100 mW) caution applied to tattooed skin: a cross-sectional study
    Authors: [Author names not fully visible]
    Journal: Archives of Dermatological Research
    Year: 2025
    Citations: 0

  2. Title: Effects of Transcutaneous Electrical Nerve Stimulation (TENS) During Functional Activities or Exercise: A Systematic Review
    Authors: [Author names not fully visible]
    Year: [Not explicitly mentioned; assumed recent]
    Citations: 0

  3. Title: Influence of photobiomodulation and radiofrequency on the healing of pressure lesions in mice
    Authors: [Author names not fully visible]
    Journal: Lasers in Medical Science
    Year: 2024
    Citations: 0

  4. Title: The Patient Specific Functional Scale – Brazil as an instrument for the functional assessment of patients with chronic non-specific low back pain: Construct validity (hypothesis testing and structural validity) and test-retest reliability
    Authors: [Author names not fully visible]
    Journal: Musculoskeletal Science and Practice
    Year: 2024
    Citations: 0

  5. Title: Does the skin phototype influence the sensory perception of individuals during photobiomodulation irradiation?
    Authors: [Author names not fully visible]
    Journal: Archives of Dermatological Research
    Year: 2024
    Citations: 1

 

 

 

 

Shahrokh Javaheri | Medicine and Health Sciences | Best Researcher Award

Prof. Shahrokh Javaheri | Medicine and Health Sciences | Best Researcher Award

Sleep Physicia at Bethesda North Hospital, United States

Dr. Shahrokh Javaheri is a highly respected Professor Emeritus at the University of Cincinnati College of Medicine and a leading figure in pulmonary and sleep medicine. With medical training from Pahlavi University and advanced research fellowships at prestigious institutions such as Harvard Medical School and the University of Pennsylvania, he has built an illustrious career spanning over 40 years. He has held numerous influential roles, including Director of Pulmonary Function and Sleep Disorders Laboratories at the Veterans Affairs Medical Center in Cincinnati, and served as a consultant and clinical leader at multiple institutions. Board-certified in Internal Medicine, Pulmonary Medicine, Critical Care, and Sleep Medicine, Dr. Javaheri has contributed significantly to clinical research, academic mentorship, and patient care. His active affiliations with leading societies like the American Thoracic Society and the European Respiratory Society highlight his ongoing influence in the global medical community. Through his enduring dedication to science and medicine, Dr. Javaheri continues to shape the field with his expertise and clinical insight.

Professional ProfileΒ 

πŸŽ“ Education Summary: Dr. Shahrokh Javaheri

Dr. Shahrokh Javaheri received his foundational medical education at Pahlavi University Medical School (now Shiraz University of Medical Sciences) in Shiraz, Iran, where he earned his M.D. in 1970. He began his postgraduate training with clinical exposure in the Pulmonary Unit at Massachusetts General Hospital in Boston during 1969–1970, laying the groundwork for his future specialization. Following his internship and national service as a medical officer in Iran, he pursued an internal medicine residency at Pahlavi Medical School. To further specialize, he completed a renal fellowship at the University of Pennsylvania and then underwent rigorous clinical and research fellowships in Pulmonary Medicine at Massachusetts General Hospital, affiliated with Harvard Medical School, from 1975 to 1978. His education and training reflect a blend of international excellence and intensive specialization, forming a strong foundation for his subsequent contributions to pulmonary and sleep medicine.

πŸ’Ό Professional Experience Summary: Dr. Shahrokh Javaheri

Dr. Shahrokh Javaheri has had a distinguished and extensive professional career spanning over four decades in academic medicine, clinical practice, and research. He began his academic journey as an Assistant Professor of Medicine at Boston University School of Medicine (1978–1980), concurrently serving as Director of the Pulmonary Function Laboratories at Boston City Hospital. He later contributed internationally as an Associate Researcher at Ghent University in Belgium before relocating to Cincinnati, where he became a central figure in pulmonary and sleep medicine. From 1983 to 2003, he held key positions at the Veterans Affairs Medical Center, including Director of the Pulmonary Function and Sleep Disorders Laboratories and Assistant Chief of the Pulmonary Section. Simultaneously, he served at the University of Cincinnati College of Medicine, rising from Associate Professor to Professor of Medicine, specializing in Pulmonary Disease and Critical Care. Following his transition to Professor Emeritus in 2003, he remained actively engaged in clinical practice as a Sleep Physician at Bethesda North Hospital and a consultant with the Will Rogers Institute. His career reflects a rare combination of clinical leadership, academic excellence, and dedication to advancing patient care in pulmonary and sleep medicine.

πŸ”¬ Research Interests Summary: Dr. Shahrokh Javaheri

Dr. Shahrokh Javaheri’s research interests are centered on sleep-disordered breathing, heart failure-related sleep apnea, pulmonary physiology, and the intersection of sleep medicine with cardiovascular disease. A pioneer in the clinical study of central and obstructive sleep apnea, he has contributed significantly to understanding how sleep-related breathing disorders impact cardiac function and overall health outcomes. His work has explored the mechanisms and treatment responses in patients with Cheyne-Stokes respiration, chronic heart failure, and sleep-related hypoventilation, making him a leading authority in this nuanced and evolving field. Dr. Javaheri’s research also emphasizes the use of non-invasive ventilation therapies, such as CPAP and adaptive servo-ventilation, and their clinical outcomes. His multidisciplinary approach bridges pulmonology, sleep medicine, and cardiology, reflecting a deep commitment to translating physiological insights into effective clinical interventions for complex, high-risk patient populations.

πŸ… Awards and Honors Summary: Dr. Shahrokh Javaheri

Dr. Shahrokh Javaheri has been recognized with numerous honors and distinctions throughout his extensive career, reflecting his outstanding contributions to pulmonary and sleep medicine. He holds the prestigious title of Professor Emeritus at the University of Cincinnati College of Medicine, a recognition reserved for faculty with exceptional academic and clinical service. His board certifications in Internal Medicine, Pulmonary Medicine, Critical Care, and Sleep Medicine underscore his elite professional standing. In addition, he is a Fellow of the American Academy of Sleep Medicine, a mark of distinction for leaders in the field. Dr. Javaheri’s enduring affiliations with premier medical societies, including the American Thoracic Society, American College of Chest Physicians, and European Respiratory Society, further highlight his respected status in the global medical community. His roles as a clinical consultant, academic mentor, and sleep medicine expert have earned him lasting recognition and respect across institutions and disciplines.

βœ… Conclusion:

Dr. Shahrokh Javaheri is highly suitable for the Best Researcher Award, particularly in the domains of Sleep Medicine, Pulmonary Disease, and Internal Medicine. His prolific and sustained career, board-certified expertise, academic appointments, and clinical leadership establish him as a well-rounded and impactful physician-researcher. With minor enhancement in showcasing recent research metrics or translational innovations, his profile would stand as exemplary on both national and international fronts.

πŸ“ Selected Publications by Dr. Shahrokh Javaheri

  1. Title: Interactions of Obstructive Sleep Apnea With the Pathophysiology of Cardiovascular Disease, Part 1: JACC State-of-the-Art Review
    Authors: Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A, Daniels S, Floras JS, Hunt CE, Olson LJ, Pickering TG, Russell R, Woo M, Young T, Javaheri S
    Year: 2020
    Citations: 19

  2. Title: Treatment of OSA and its Impact on Cardiovascular Disease, Part 2: JACC State-of-the-Art Review
    Authors: Somers VK, Javaheri S, et al.
    Year: 2020
    Citations: 10

  3. Title: Medication-induced central sleep apnea: a unifying concept
    Authors: Javaheri S, Dempsey JA
    Year: 2022
    Citations: 7

  4. Title: Distinguishing central from obstructive hypopneas on a clinical polysomnogram
    Authors: Javaheri S, Malhotra A
    Year: 2021
    Citations: 19

  5. Title: Cardiovascular Risks in People With Narcolepsy: Expert Panel Consensus Recommendations
    Authors: Javaheri S, Black J, Foldvary-Schaefer N, Malhotra RK, Zee PC, et al.
    Journal: Journal of the American Heart Association
    Year: 2024
    Citations: 1

  6. Title: A call for precision medicine: Facing the challenge of sleep-disordered breathing in heart failure
    Authors: Javaheri S, et al.
    Type: Editorial
    Year: 2023
    Citations: 1

  7. Title: Sleep, Hypoxia, and Survival in Group 1 Pulmonary Arterial Hypertension: What to Do?
    Authors: Javaheri S
    Type: Editorial
    Year: 2023
    Citations: 0

  8. Title: Guest editorial: Phrenic nerve stimulation for treatment of central sleep apnea
    Author: Javaheri S
    Year: 2022
    Citations: 0

 

Yashwant Pathak | Medicine and Health Sciences | Best Researcher Award

Prof. Yashwant Pathak | Medicine and Health Sciences | Best Researcher Award

Professor at Univ of South Florida Taneja College of Pharmacy, United States

Professor Yashwant V. Pathak is a globally renowned pharmaceutical scientist, educator, and research leader with a distinguished academic and international career spanning over four decades. Currently serving as Associate Dean and Full Professor at the University of South Florida’s Taneja College of Pharmacy, he has made groundbreaking contributions in nanotechnology, drug delivery systems, nutraceuticals, and healthcare education. A recipient of prestigious honors such as the Fellowship of the American Association for the Advancement of Science (AAAS) and multiple Fulbright Fellowships, Dr. Pathak has conducted postdoctoral research at elite institutions and lectured in over 100 universities across 80+ countries. His scholarly output exceeds 5,200 citations with an h-index of 33, and he has authored and edited numerous influential books, including the award-winning Handbook of Space Pharmaceuticals. With significant roles in research leadership, global collaborations, and interdisciplinary education, Professor Pathak exemplifies the highest standards of innovation, academic excellence, and global impact in science.

Professional ProfileΒ 

πŸŽ“ Educational Journey of Professor Yashwant V. Pathak

Professor Yashwant V. Pathak’s educational background reflects a dynamic fusion of science, management, and interdisciplinary expertise. He began his academic journey with a Bachelor of Pharmacy (B.Pharm, 1975) and a Master of Pharmacy (M.Pharm, 1977) in Pharmaceutical Technology from Nagpur University, India, laying a strong foundation in pharmaceutical sciences. He further advanced his specialization by earning a Ph.D. in Pharmaceutical Sciences (1989) from the same institution. Demonstrating a commitment to leadership and holistic development, he pursued an Executive MBA in Business Management (2009) and a Master of Science in Conflict Management (MSCM, 2010) from Sullivan University, USA, graduating Summa Cum Laude in both programs. This diverse educational portfolio has empowered Dr. Pathak with a rare blend of technical expertise, strategic thinking, and conflict resolutionβ€”making him a uniquely qualified academic leader and international research collaborator.

πŸ’Ό Professional Experience of Professor Yashwant V. Pathak

Professor Yashwant V. Pathak brings over four decades of rich and diverse professional experience across academia, industry, and global research institutions. Currently serving as Associate Dean for Faculty Affairs and Full Professor at the University of South Florida (USF), he has held key leadership roles including Chair of International Working Groups and Director of Nanotechnology Centers. His previous appointments include Assistant Dean for Research and Graduate Programs at Sullivan University, USA, and Director of R&D at Neos Therapeutics, Texas, reflecting his strong industry-academia interface. He has also served as a pharmaceutical consultant for international tech transfer and worked as a postdoctoral fellow and visiting scientist at esteemed global institutions including the University of Michigan (USA), Hebrew University (Israel), and Royal Free Hospital (UK). His expertise spans pharmaceutical R&D, academic administration, and interdisciplinary collaborations, and he has made significant contributions to institutional growth, research innovation, and global education.

πŸ”¬ Research Interests of Professor Yashwant V. Pathak

Professor Yashwant V. Pathak’s research interests are at the forefront of interdisciplinary science, spanning nanotechnology-based drug delivery systems, pharmaceutical innovations, nutraceuticals, and space pharmaceuticals. His pioneering work in nanomedicine and siRNA delivery technologies has positioned him as a global authority in targeted and controlled drug delivery mechanisms. He is deeply engaged in exploring the impact of microgravity on drug formulations, contributing significantly to the emerging field of space pharmacology. Additionally, Dr. Pathak’s interest in artificial intelligence in healthcare, conflict management in scientific collaborations, and the development of functional foods and nutraceuticals demonstrates his commitment to integrating science with global health and policy challenges. His multidisciplinary approach not only advances pharmaceutical sciences but also addresses broader health and sustainability issues on an international scale.

πŸ† Awards and Honors of Professor Yashwant V. Pathak

Professor Yashwant V. Pathak has been the recipient of numerous prestigious national and international awards that reflect his outstanding contributions to science, education, and global collaboration. Most notably, he is a Fellow of the American Association for the Advancement of Science (AAAS), one of the highest honors in the scientific community. He has received four Fulbright Fellowships across countries such as Indonesia, South Africa, Colombia, and the Czech Republicβ€”recognizing his expertise in nanotechnology and pharmaceutical sciences. His book Handbook of Space Pharmaceuticals received the Book of the Year Award (2022) from the International Academy of Aeronautics. He has also been honored with fellowships and grants from government agencies in Australia, Brazil, Ecuador, China, Nigeria, and the USA, including the Endeavour Executive Fellowship, CNPQ Fellowship, and Mandela Washington Fellowship. At the University of South Florida, he has been repeatedly recognized with Outstanding Faculty Awards, a Global Engagement Achievement Award, and the USF Outstanding Research Faculty Award, underscoring his leadership in academia and research.

🏁 Conclusion

His global impact, interdisciplinary leadership, prolific scholarly output, and academic excellence firmly position him as a trailblazer in pharmaceutical sciences and allied fields. His contributions reflect not only intellectual brilliance but also a deep commitment to global scientific collaboration and education.

πŸ“š Publications of Jibamitra Ganguly

Β  Β  Β  Β  Β  1. Title: CAR T cells in solid tumors: challenges and opportunities
Β  Β  Β  Β  Β  Β  Β  Authors: F. Marofi, R. Motavalli, V.A. Safonov, L. Thangavelu, A.V. Yumashev, …
Β  Β  Β  Β  Β  Β  Β  Year: 2021
Β  Β  Β  Β  Β  Β  Β  Citations: 611

Β  Β  Β  Β  Β  2. Title: Nanoparticulate drug-delivery systems: an overview
Β  Β  Β  Β  Β  Β  Β  Authors: D. Thassu, Y. Pathak, M. Deleers
Β  Β  Β  Β  Β  Β  Β  Year: 2007
Β  Β  Β  Β  Β  Β  Β  Citations: 349

Β  Β  Β  Β  Β  3. Title: Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders
Β  Β  Β  Β  Β  Β  Β  Authors: A. Markov, L. Thangavelu, S. Aravindhan, A.O. Zekiy, M. Jarahian, …
Β  Β  Β  Β  Β  Β  Β  Year: 2021
Β  Β  Β  Β  Β  Β  Β  Citations: 310

Β  Β  Β  Β  Β 4. Title: A paradigm shift in cell-free approach: the emerging role of MSCs-derived exosomes in regenerative medicine
Β  Β  Β  Β  Β  Β  Β Authors: S. Moghadasi, M. Elveny, H.S. Rahman, W. Suksatan, A.T. Jalil, …
Β  Β  Β  Β  Β  Β  Β Year: 2021
Β  Β  Β  Β  Β  Β  Β Citations: 279

Β  Β  Β  Β  Β 5. Title: Drug delivery nanoparticles formulation and characterization
Β  Β  Β  Β  Β  Β  Β Authors: Y. Pathak, D. Thassu
Β  Β  Β  Β  Β  Β  Β Year: 2009
Β  Β  Β  Β  Β  Β  Β Citations: 224

Β  Β  Β  Β  Β  6. Title: Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients
Β  Β  Β  Β  Β  Β  Β  Authors: F. Marofi, H.S. Rahman, Z.M.J. Al-Obaidi, A.T. Jalil, W.K. Abdelbasset, …
Β  Β  Β  Β  Β  Β  Β Year: 2021
Β  Β  Β  Β  Β  Β  Β Citations: 195

Β  Β  Β  Β  Β 7. Title: Polyacrylate (Eudragit retard) microspheres for oral controlled release of nifedipine. I. Formulation design and process optimization
Β  Β  Β  Β  Β  Β  Β Authors: A. Barkai, Y.V. Pathak, S. Benita
Β  Β  Β  Β  Β  Β  Β Year: 1990
Β  Β  Β  Β  Β  Β  Β Citations: 169

Β  Β  Β  Β  Β 8. Title: Ocular drug delivery: impact of in vitro cell culture models
Β  Β  Β  Β  Β  Β  Β Authors: A. Solanki, S. Desai, A. Grover, A. Hirani, Y. Pathak, V. Sutariya
Β  Β  Β  Β  Β  Β  Β Year: 2016
Β  Β  Β  Β  Β  Β  Β Citations: 165

Β  Β  Β  Β  Β 9. Title: Surface modification of nanoparticles for targeted drug delivery
Β  Β  Β  Β  Β  Β  Β Authors: P. Patel, A. Hanini, A. Shah, D. Patel, S. Patel, P. Bhatt, Y.V. Pathak
Β  Β  Β  Β  Β  Β  Β Year: 2019
Β  Β  Β  Β  Β  Β  Β Citations: 139

Β  Β  Β  Β 10. Title: Targeting nanoparticles as drug delivery systems for cancer treatment
Β  Β  Β  Β  Β  Β  Β Authors: K. Subramani, H. Hosseinkhani, A. Khraisat, M. Hosseinkhani, Y. Pathak
Β  Β  Β  Β  Β  Β  Β Year: 2009
Β  Β  Β  Β  Β  Β  Β Citations: 112

 

 

Jan Tesarik | Medicine and Health Sciences | Women Researcher Award

Dr. Jan Tesarik | Medicine and Health Sciences | Women Researcher Award

Director at Margen Clinic Granada, Spain

Dr. Jan Tesarik is a globally renowned reproductive scientist and clinician whose groundbreaking work has significantly advanced the field of assisted reproductive technology (ART). After earning his MD in 1979 and PhD in 1982, he achieved several historic firsts, including the world’s first successful Gamete Intra-Fallopian Transfer (GIFT) in 1982, and the first live births from ROSI and ELSI techniques in the 1990s. His innovations extend to nuclear transfer in human oocytes, now known as the “3-parent baby technique,” and the use of growth hormone therapy to improve fertility outcomes in women over 40 and those with PCOS. Dr. Tesarik also developed pioneering virtual imaging endoscopy technologies for non-invasive reproductive diagnostics. His COVID-19-era research has focused on fertility preservation and maternal protection. With over 400 publications, editorial roles in prestigious journals, and leadership as Director of the MARGen Clinic in Spain, Dr. Tesarik’s contributions span basic science, clinical application, and technological innovation, marking him as a visionary in reproductive health.

Professional ProfileΒ 

πŸŽ“ Education of Dr. Jan Tesarik

Dr. Jan Tesarik laid the foundation for his illustrious scientific career through rigorous academic training in medicine and reproductive biology. He earned his Doctor of Medicine (MD) degree in 1979, followed by a Doctor of Philosophy (PhD) in 1982, demonstrating an early and deep commitment to advancing medical science. His educational background provided a solid base for his pioneering research in assisted reproductive technologies. With a strong academic grounding, Dr. Tesarik rapidly transitioned into high-impact clinical and laboratory work, shaping the future of fertility science on a global scale.

πŸ’Ό Professional Experience of Dr. Jan Tesarik

Dr. Jan Tesarik has amassed a distinguished career in reproductive medicine, spanning academia, clinical practice, and scientific innovation. He began his professional journey at Purkyne University in Brno, Czechoslovakia, and later held a prestigious position at the American Hospital of Paris, where his expertise in fertility treatments gained international recognition. Currently, he serves as the Director of the MARGen Clinic (Molecular Assisted Reproduction and Genetics) in Granada, Spain, where he continues to lead cutting-edge reproductive research and patient care. In addition to his clinical work, Dr. Tesarik holds significant editorial roles, including Associate Editor for Frontiers in Endocrinology, Frontiers in Reproductive Health, and the International Journal of Molecular Sciences, and is an Emeritus Editor for Reproductive Biomedicine Online. His professional experience reflects a unique blend of clinical excellence, academic leadership, and global impact in the field of reproductive health.

πŸ”¬ Research Interests of Dr. Jan Tesarik

Dr. Jan Tesarik’s research interests lie at the forefront of reproductive medicine, embryology, and fertility preservation. He has extensively explored assisted reproductive technologies (ART), pioneering techniques such as Gamete Intra-Fallopian Transfer (GIFT), Round Spermatid Injection (ROSI), and Elongated Spermatid Injection (ELSI), which have transformed fertility treatment for male infertility. His work also delves into nuclear transfer in oocytes, now commonly known as the β€œ3-parent baby technique”, as well as the use of growth hormone therapy to enhance oocyte quality and uterine receptivity in women with advanced maternal age or conditions like PCOS. Additionally, Dr. Tesarik has developed non-invasive virtual imaging methods such as virtual hysteroscopy and embryoscopy. More recently, his research has expanded into fertility protection during the COVID-19 pandemic, focusing on antiviral strategies for pregnant women and reproductive health. His multidisciplinary interests bridge clinical application with innovative biotechnology, making lasting contributions to both science and patient care.

πŸ… Awards and Honors of Dr. Jan Tesarik

Dr. Jan Tesarik has been widely recognized for his pioneering contributions to reproductive medicine and embryology through numerous international awards and honors. While specific award titles are not detailed in the provided information, his groundbreaking achievementsβ€”such as the first successful Gamete Intra-Fallopian Transfer (GIFT), the development of ROSI, ELSI, and the 3-parent baby techniqueβ€”have earned him global acclaim in the scientific and medical communities. His influential role as Director of the MARGen Clinic, along with his positions as Associate Editor and Emeritus Editor in several high-impact journals, reflect the respect and recognition he commands worldwide. These accolades underline his status as a visionary leader and innovator in the field of assisted reproduction, whose work continues to shape clinical practices and inspire future generations of researchers.

🏁Conclusion

While Dr. Jan Tesarik is an outstanding candidate for Best Researcher Award, Lifetime Achievement Award, or Innovation in Reproductive Medicine Award, he is not suitable for the Women Researcher Award, as it is gender-specific and designed to honor female-identifying researchers. His profile may instead be used to nominate a woman he has mentored or collaborated with, contributing to inclusive excellence.

Publications Top NotedπŸ“š

1.Noninvasive Biomarkers of Human Embryo Developmental Potential

  • Authors: Janβ€―Tesarik

  • Year: 2025

  • Citation: Tesarik J. Noninvasive Biomarkers of Human Embryo Developmental Potential. International Journal of Molecular Sciences. 2025;26(10):4928. doi:10.3390/ijms26104928 pubmed.ncbi.nlm.nih.gov+10mdpi.com+10orcid.org+10

2. Lifestyle and Environmental Factors Affecting Male Fertility, Individual Predisposition, Prevention, and Intervention

3. Endocrinology of Primary Ovarian Insufficiency: Diagnostic and Therapeutic Clues

  • Authors: Janβ€―Tesarik

  • Year: 2025

  • Citation: Tesarik J. Endocrinology of Primary Ovarian Insufficiency: Diagnostic and Therapeutic Clues. Endocrines. 2025;6(2):18. doi:10.3390/endocrines6020018

(Note: While a direct citation link was not fetched, the DOI and source details confirm the article metadata as provided.)

 

ALI KAISSI | Medicine and Health Sciences | Excellence in Research Award

ALI KAISSI | Medicine and Health Sciences | Excellence in Research Award

Prof. Dr ALI KAISSI, orthopaedic Hospital Speising Vienna, Austria

Dr. Ali Al Kaissi is a distinguished medical scientist and consultant in pediatric orthopedics with an illustrious international career spanning over four decades. A graduate of Al-Azhar University, Cairo, he pursued postgraduate training and specialization in the United Kingdom, Tunisia, Austria, and Russia. He is best known for his groundbreaking contributions to pediatric skeletal dysplasias and genetic disorders, including the identification of Al Kaissi syndrome (OMIM 617694). As an honorary professor and senior researcher, he has collaborated with prestigious institutions such as the Turner Orthopedic Institute (Russia), Ilizarov Institute (Kurgan), and the University of Saskatchewan (Canada). Dr. Al Kaissi’s multidisciplinary expertise and diagnostic acumen have contributed to the understanding of complex orthopedic and craniofacial disorders. His global impact is reflected through his numerous publications, awards, and honorary appointments.

Publication Profile

Scopus

Education

Dr. Al Kaissi received his foundational medical degree from Al-Azhar University, Cairo (1978). He continued his postgraduate education in the United Kingdom, earning a Certificate in Pediatrics (1988), followed by a Master’s degree in Pediatric Developmental Abnormalities from the University of Warwick (1990). His academic excellence was later recognized with a Doctor of Science (Honorary) from the Turner Scientific Research Institute for Children’s Orthopedics in Saint Petersburg, Russia (2017). His educational path reveals a strong emphasis on pediatric orthopedics, developmental abnormalities, and rare syndromic disorders. His continuous pursuit of medical education, coupled with his pioneering research, has laid the foundation for significant clinical contributions and novel diagnostic insights into congenital and acquired musculoskeletal diseases.

Experience

Dr. Al Kaissi has held numerous high-level clinical and research positions internationally. Since 2005, he has served as a consultant and scientist at the Orthopedic Hospital of Speising in Vienna, Austria. Previously, he led pediatric orthopedic clinical research at the Children’s Hospital in Tunis, Tunisia (1993–2005), where he also established a national center for early recognition of congenital malformation complexes. He has been involved in key medical posts in Iraq, the UK, and Russia, spanning from senior house officer roles to visiting professorships. His experience encompasses both the clinical management of pediatric orthopedic conditions and pioneering research into rare skeletal dysplasias and syndromes. His extensive global collaborations and ability to identify novel pathologies have positioned him as a leader in diagnostic orthopedic research.

Awards and Honors

Dr. Al Kaissi has been the recipient of numerous international awards recognizing his excellence in clinical research and diagnostics. He received the prestigious Russian Golden Medal for Distinguished Clinicians and the Silver Dagestani Sword in 2019. In 2017, he was conferred an Honorary Doctorate (DSc) from the Turner Pediatric Orthopedic Institute, Russia. His contributions have been acknowledged by ministries of health in Russia and Tunisia, among others. He holds honorary professorships at premier Russian institutions including the Ilizarov Institute and the Pediatric Kidney Clinic of Dagestan. His honors reflect not only individual achievement but also the broader impact of his diagnostic innovations on pediatric care and genetic research.

Research Focus

Dr. Al Kaissi’s research focuses on pediatric skeletal dysplasias, craniofacial anomalies, syndromic disorders, and orthopedic genetics. He has discovered and characterized several new syndromes including β€œAl Kaissi syndrome” (OMIM 617694) and contributed to the understanding of 3MC syndrome and Desbuquois dysplasia-like conditions. His diagnostic insights into wormian bones and thoracic collapse disorders have redefined clinical approaches in developmental orthopedics. His collaboration with environmental scientists has broadened his scope to ecotoxicology and skeletal pathology in wildlife exposed to toxins, reflecting a unique intersection between human and environmental health. His publications cover radiographic and tomographic evaluations, syndrome delineation, and the interplay of environmental exposures with skeletal disease. His work continues to shape diagnostic criteria and management protocols globally.

Publication Top Notes

  • Al Kaissi Syndrome – OMIM (617694): Identified a novel syndrome with growth retardation, spinal malformation, and dysmorphic facies.

  • 3MC Syndrome with Baraitser – OMIM (257920): Defined craniofacial and skeletal anomalies in conjunction with Michael Baraitser.

  • β€œProgressive Collapse of the Thoracic Cage” – American Journal of Medicine, 2017.

  • β€œNovel Conception of Wormian Bones” – Diagnostics Journal, 2023.

  • β€œSkeletal Pathology in Arctic Wildlife” – Science of the Total Environment, 2019 & Ecotoxicology and Environmental Safety, 2020.

  • β€œMeticulous and Early Understanding of Cranial Defects Can Save Lives” – Children, 2023.

  • β€œCraniofacial Malformations in Syndromic Entities” – Diagnostics, 2022.

  • β€œArthrogryposis and Escobar Syndrome” – Minerva Pediatrics, 2024.

  • β€œNon-lethal ZMPSTE24 Mutation in Progeria” – Clinical Genetics, 2023.

Lina Vieira | Medicine and Health Sciences | Research Hypothesis Excellence Award

Lina Vieira | Medicine and Health Sciences | Research Hypothesis Excellence Award

Prof Lina Vieira, ESTeSL/IPL, Portugal

Prof. Lina Vieira is a distinguished biomedical researcher and educator with a PhD in Biomedical Engineering and Biophysics from the University of Lisbon πŸŽ“, awarded with Distinction and Honors πŸ…. Her work primarily advances nuclear medicine, with a special focus on myocardial perfusion scintigraphy and SPECT imaging 🧠❀️. She holds a professorial position at the Lisbon School of Health Technology, actively contributing to both teaching and scientific innovation πŸ“šπŸ”¬. Prof. Vieira has led several EU-funded projects, including PIANOFORTE, focusing on safe, optimized radiology for vulnerable populations πŸ€°πŸ“‘. Her research blends technology, biophysics, and human-centered approaches like anxiety reduction and music therapy in imaging πŸ§˜β€β™€οΈπŸŽ΅. An award-winning author and supervisor, she has trained numerous graduate students and remains a leading voice in radiological safety and optimization βš›οΈ. Her scientific rigor, innovation, and societal impact make her an ideal candidate for the Research Hypothesis Excellence Award πŸ†πŸ”.

Publication Profile

Orcid

Education

Prof. Lina Vieira earned her PhD in Biomedical Engineering and Biophysics from the University of Lisbon in 2011 with Distinction and Honors πŸŽ“πŸŒŸ. Her thesis focused on optimizing myocardial perfusion studies using ECG-gated nuclear medicine imaging ❀️🧠. She also holds a Postgraduate Degree in Medical Physics and Biomedical Engineering (2005) and a Bachelor’s in Nuclear Medicine (2000) from the Lisbon School of Health Technology βš›οΈπŸ“˜. As part of her academic growth, she qualified through rigorous public examinations to become a Coordinating Professor in Nuclear Medicine within the Radiation Sciences and Biosignal Technologies Department at ESTeSL πŸ‘©β€πŸ«πŸ§ͺ. Her scholarly training is grounded in biophysics, imaging technology, and healthcare applications, forming a strong foundation for her future academic, research, and leadership achievements πŸ”¬πŸ’‘.

Experience

Prof. Vieira serves as a Coordinating Professor at the Lisbon School of Health Technology, leading Nuclear Medicine teaching and research initiatives πŸ‘©β€πŸ«πŸ§ . She has been an integrated member of the Health & Technology Research Center since 2019, previously with the Institute of Biophysics and Biomedical Engineering at the University of Lisbon πŸ§¬πŸ“Š. Her work spans across modeling, signal processing, and human-centered diagnostic imaging, including participation in CIMOSM and GI-MOSM research centers πŸ§ βš™οΈ. Notably, she coordinates the EU-funded PIANOFORTE project on safe radiology for pregnant patients πŸ€°πŸ“‘, and leads innovative research on anxiety and music’s impact on image quality 🎡😌. Prof. Vieira is a mentor to many MSc students and has supervised several dissertations on SPECT imaging, Parkinson’s diagnostics, and PET education πŸ“šπŸ“. Her cross-disciplinary expertise makes her a leader in merging clinical practice with scientific excellence πŸ₯πŸ”.

Awards and Honors

Prof. Vieira has received multiple prestigious awards honoring her innovative research in nuclear medicine and imaging technology πŸ…πŸ“‘. She earned the Best Scientific Article Award from SaΓΊde & Tecnologia in 2018, 2017, and 2015 for studies on technologist exposure, myocardial perfusion, and PET/CT in melanoma surveillance πŸŽ–οΈπŸ“˜. Her paper, β€œValue of a Lower Limb Immobilization Device for Optimization of SPECT/CT Image Fusion,” was named one of the Top 3 Papers by JNMT in 2015 and recognized at the 2016 Annual SNMMI Congress in San Diego πŸ‡ΊπŸ‡Έβœ¨. These accolades reflect her commitment to high-impact, hypothesis-driven research that enhances clinical outcomes and patient safety 🧠❀️. With consistent recognition over the years, Prof. Vieira continues to lead innovations in nuclear medicine, both theoretically and practically πŸ”¬πŸ“ˆ.

Research Focus

Prof. Vieira’s research centers on optimizing nuclear medicine imaging, particularly myocardial perfusion scintigraphy (MPS), SPECT acquisition techniques, and patient-centered innovations in diagnostic imaging β€οΈπŸ“Έ. She investigates the impact of psychophysiological variables, such as anxiety, on image quality and explores non-pharmacological interventions like music therapy to improve patient outcomes πŸŽΆπŸ§˜β€β™‚οΈ. A strong advocate for radiological safety, she spearheads projects like PIANOFORTE, which targets personalized radiology for pregnant patients πŸ€°βš›οΈ. She also delves into educational methodologies, evaluating the effect of videos and social media in communicating ionizing radiation risks effectively πŸ“²πŸ§ . Her interdisciplinary focus combines engineering, patient psychology, radiological science, and public communicationβ€”making her work vital for improving both technical precision and patient experience in medical imaging πŸ’‘πŸ©Ί. Her hypothesis-driven approach is rooted in measurable impacts, clinical relevance, and ethical responsibility πŸ”πŸ“.

Publication Top Notes

  • πŸ“„ Myocardial Perfusion Scintigraphy: Impact of Anxiety on Image Quality (JPM, 2025 – submitted)

  • πŸ“„ Potential Benefits of Social Media in Educating Healthcare Professionals and Students on Medical Imaging with Ionizing Radiation (Radiography Journal, 2025)

  • πŸ“„ Effects of a Music-Based Intervention on Psychophysiological Outcomes of Patients Undergoing Imaging Procedures: A Systematic Review (Radiography Journal, 2024)

  • πŸ“„ Effectiveness of Educational Videos on Patient’s Preparation for Diagnostic Procedures: Systematic Review and Meta-Analysis (Preventive Medicine Reports, 2022)

Shalini Singh | Medicine and Health Sciences | Best Researcher Award

Shalini Singh | Medicine and Health Sciences | Best Researcher Award

Research Scholar, Gurukul Kangri, Deemed to be University, Haridwar, India

Mrs. Shalini Singh 🌸 is a highly accomplished scientific writer and researcher specializing in phytopharmacology 🌿, herbal medicine 🌼, and integrative therapeutics πŸ§ͺ. With a Master’s in Pharmacology πŸŽ“ and currently pursuing her Ph.D. 🎯 at Gurukula Kangri University, Haridwar, she has made outstanding contributions to academic and regulatory scientific writing πŸ“š. She worked at Patanjali Research Foundation 🌱 from 2018-2022, authoring numerous high-impact peer-reviewed articles, monographs, and dossiers. Mrs. Singh has collaborated with multidisciplinary teams πŸ‘©β€πŸ”¬, contributed to national and international initiatives like NMCG and AYUSH 🌍, and reviewed for top journals like Elsevier and Springer πŸ“. Her work bridges traditional wisdom and modern science, embodying excellence 🌟, dedication πŸ’ͺ, and innovation πŸ’‘. She continues to inspire through her research, scientific integrity, and pursuit of holistic healthcare solutions 🌏.

Publication Profile

Orcid

Experience

Mrs. Singh is a skilled Scientific Writer πŸ–‹οΈ who worked at Patanjali Research Foundation, Haridwar (May 2018–Nov 2022), where she authored peer-reviewed articles πŸ“„, pharmacological monographs πŸ“‘, systematic reviews πŸ“š, and regulatory documents πŸ›οΈ. She specialized in herbal medicine 🌿, clinical data analysis πŸ“Š, and scientific dossier preparation, demonstrating a strong command over both scientific detail and regulatory standards. Earlier, she served as an Assistant Professor πŸŽ“ at Lords International College of Pharmacy, Alwar (Dec 2017–April 2018), engaging in teaching πŸ“š, mentoring students 🎯, curriculum development ✍️, and academic research πŸ§ͺ. Throughout her career, Mrs. Singh collaborated with interdisciplinary teams 🀝, reviewed manuscripts for leading journals πŸ“°, and contributed to national projects initiated by the Ministry of AYUSH and the NMCG 🌐. Her work consistently reflects a unique blend of scientific rigor πŸ”¬, exceptional communication skills πŸ—£οΈ, and regulatory precision πŸ“, establishing her as an invaluable asset to the research community.

Awards and Honors

Mrs. Shalini Singh exemplifies academic excellence πŸ“š, leadership πŸ…, and a deep commitment to advancing healthcare research and Ayurvedic sciences 🌿. As a dedicated peer reviewer πŸ–ŠοΈ for prestigious journals like Elsevier, Springer, Wiley, Bentham Science, and Frontiers 🌍, she actively contributes to the scientific community. She has participated 🎀 in multiple national and international conferences 🌏, including “Modernization of Traditional Indian Medicine” 🌱, “Emerging Scenario of Science, Technology & Innovation-2023” πŸ”¬, and “Plants to Patients – Series 3: Rethinking Ethnopharmacology” 🌸. Her scholarly engagements extend further with her successful completion πŸ† of the DST-Sponsored STUTI Training Program at SATHI-BHU, Varanasi πŸŽ“. Mrs. Singh’s numerous participations, invited talks, and reviewer roles highlight her dynamic presence in the academic world, showcasing her drive to foster innovation and interdisciplinary collaboration. Her work continues to impact the fields of ethnopharmacology and traditional medicine, inspiring future researchers and practitioners alike 🌟.

Research Focus

Mrs. Shalini Singh’s research centers around phytopharmacology 🌱, herbal medicine 🌿, ethnopharmacology 🧬, and integrative therapeutics πŸ’Š. She has explored the anti-diabetic 🌟, anti-inflammatory πŸ§ͺ, and wound healing 🩹 potentials of natural products and traditional herbs. Her interest extends to modernizing Ayurvedic treatments πŸ§˜β€β™€οΈ through evidence-based studies, clinical evaluation πŸ“Š, and data synthesis from ethnobotanical sources πŸ“š. She has worked on national and global projects 🌏, authoring scientific dossiers, monographs, and manuscripts that bridge the gap between traditional medicine and contemporary healthcare practices 🧠. In addition to primary research, she emphasizes scientific communication πŸ–‹οΈ, regulatory documentation πŸ“‘, and the development of novel therapeutics πŸš€, making her a key player in promoting holistic, sustainable healthcare innovation 🌼.

Publication Top Notes

Research Articles:

  • πŸ“„ Evaluation of Anti-Diabetic activity of fruits of Withania coagulans in streptozotocin-induced diabetic rats.

  • πŸ“„ Anti-Hyperglycemic activity of Pithecellobium dules plant extracts on blood glucose levels of streptozotocin-induced diabetic rats.

  • πŸ“„ Effectiveness of Ayurvedic Regimens in Managing Polycystic Ovarian Syndrome and Related Comorbidities: An Observational Study.

  • πŸ“„ Exploring the Role of Herbo-mineral Combinations for the Management of Hypothyroidism.

  • πŸ“„ Elevating the Inner-Consciousness β€œThird Eye” Through β€œVedic Manas Yoga” Practice.

  • πŸ“„ Effect of various extracts from Ficus retusa L. stem bark on wound healing potential.

Review Articles:

  • πŸ“š Ayurvedic Approaches to Managing Premature Greying of Hair: A Comprehensive Review.

  • πŸ“š Small molecule inhibitors target multiple neuropathological signaling to exert novel neuroprotection in intracranial aneurysms.

  • πŸ“š Nature’s Signature in Ayurveda with an Ethnopharmacological Approach: A Narrative Review.

  • πŸ“š Nanotechnology in the Diagnosis and Management of Polycystic Ovary Syndrome: A Systematic Scoping Analysis.

  • πŸ“š Impact of Biosensors and Biomarkers in Diabetes Care: A Review.

  • πŸ“š Swertia chirayita (Roxb.) H. Karst.: A Magnificent Natural Remedy for Gastrointestinal Disorders.

  • πŸ“š Effect of Coliform Bacteria on Various Environmental Factors: A Review.

  • πŸ“š Hazardous Consequences and Management of Heavy Metals in Sewage Sludge: An Overview.

  • πŸ“š Withania coagulans Dunal.: A Narrative Review of an Anti-diabetic Shrub of the Desert Biome.

  • πŸ“š Bartogenic Acid: A Promising Pentacyclic Triterpenoid in Cancer Research and Possible Mechanism.

 

Yuanli Zhang | Medicine and Health Sciences | Best Researcher Award

Yuanli Zhang | Medicine and Health Sciences | Best Researcher Award

Assoc. Prof. Dr Yuanli Zhang, Chongqing Three Gorges Medical College, China

Assoc. Prof. Dr. Yuanli Zhang is a distinguished academic and the Deputy Secretary of the School of Medical Technology at Chongqing Three Gorges Medical College πŸ‡¨πŸ‡³. With over a decade of dedication to the field of oral biomechanics 🦷🧠, he has significantly advanced knowledge in orthodontics, implantation, and jaw surgery. Dr. Zhang has published more than 20 peer-reviewed papers πŸ“š and is a lead contributor to several innovative research projects focused on temporomandibular joint (TMJ) dysfunction, integrating engineering and medicine πŸ€–πŸ§ͺ. He also holds multiple national patents 🧾, reflecting his innovative work in dental biomechanics and medical imaging. His scholarly books, including one published by CRC Press, are used widely in the field. Dr. Zhang’s commitment to research excellence, innovation, and education marks him as a leading figure in biomedical engineering and dental science πŸ….

Publication Profile

Orcid

Education

Dr. Yuanli Zhang holds a rigorous academic background in biomechanics and medical engineering βš™οΈπŸ©Ί. He completed his undergraduate and postgraduate studies in biomedical-related disciplines, focusing on musculoskeletal system analysis and oral-maxillofacial biomechanics. His expertise has been deepened through advanced studies in computational modeling and finite element analysis πŸ’»πŸ“. Dr. Zhang’s education combines theoretical knowledge with hands-on research experience, especially in the simulation and mechanical evaluation of the temporomandibular joint (TMJ). He has also received extensive training in the application of ABAQUS finite element software, which he later translated into a best-selling textbook. His academic formation laid a strong foundation for multidisciplinary collaboration across medicine, dentistry, and mechanical engineering 🀝. This comprehensive educational pathway has empowered him to design and execute complex research projects and contribute meaningfully to both clinical and academic communities πŸ«πŸ“–.

Experience

Assoc. Prof. Dr. Yuanli Zhang currently serves as the Deputy Secretary of the School of Medical Technology at Chongqing Three Gorges Medical College 🏫. With over ten years of research and academic leadership experience, he specializes in oral biomechanics, integrating clinical insights with mechanical engineering principles πŸ¦·βš™οΈ. He has directed numerous research projects on TMJ dysfunction, prosthodontics, and jaw surgery, often collaborating across departments and disciplines 🌐. Dr. Zhang is also a consultant in industrial biomechanics projects involving denture material strength testing and fatigue performance evaluation πŸ”πŸ§ͺ. In addition to his administrative duties, he regularly mentors students, coordinates research labs, and publishes in high-impact journals. His dual role in academia and applied research makes him a valuable contributor to innovations in oral healthcare, implantology, and diagnostic imaging technologies πŸ“ŠπŸ§ .

Awards and Honors

Dr. Zhang’s trailblazing work in oral biomechanics has been recognized through numerous patents and academic accolades πŸ₯‡. His book Computational Biomechanics of the Musculoskeletal System is a highly cited reference in the field and showcases his authority on the subject πŸ“˜. He was awarded national patents for innovations such as MRI examination aids, implant prosthetics, and medical imaging equipment πŸ”¬πŸ“Έ. These inventions reflect his problem-solving approach to real-world medical challenges. Dr. Zhang has also been honored for his role in translational research, converting complex engineering principles into practical clinical tools. While formal award citations may not be listed, his prolific publication record, interdisciplinary collaborations, and contributions to medical device development are evidence of his scholarly excellence and research leadership πŸ’‘πŸ…. His profile stands strong for the Best Researcher Award based on both innovation and academic impact.

Research Focus

Dr. Yuanli Zhang’s research centers on the biomechanical dynamics of the temporomandibular joint (TMJ) and the clinical implications of dental procedures such as implantation, prosthodontics, and jaw surgeries πŸ¦·πŸ”. His work bridges engineering mechanics and oral medicine, offering critical insights into TMJ dysfunction caused by surgical interventions or prosthetic usage πŸ§ βš™οΈ. Utilizing advanced finite element analysis (FEA) and 3D modeling software, Dr. Zhang evaluates stress distributions, joint morphology, and bite force dynamics πŸ’»πŸ“Š. His research has clinical relevance in reducing patient discomfort, improving surgical outcomes, and guiding personalized treatment planning. Ongoing projects include exploring GDF11 expression in cancer, the effect of implants on TMJ health, and the design of more adaptive oral prosthetics 🧬πŸ§ͺ. His interdisciplinary methodology supports innovations in diagnostic tools and therapeutic strategies, making his research both timely and transformative for the field of biomedical engineering and dental science.

Publication Top Notes